Lv1
50 积分 2026-01-15 加入
A novel SOCS5/miR‐18/miR‐25 axis promotes tumorigenesis in liver cancer
3个月前
已完结
Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers
3个月前
已完结
EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
4个月前
已完结
皖公网安备34019202002308
